Cannvas Selected to Join The International Cannabis Alliance as Exclusive Provider of Cannabis Education
Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has joined the International Cannabis Alliance (“InterCannAlliance”), bringing advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe, as its exclusive provider of cannabis education. The InterCannAlliance is an international project led by New Frontier Data, an independent, technology-driven analytics company specializing in the cannabis industry.
“We are proud to join the International Cannabis Alliance in its efforts to educate future leaders in the global cannabis industry and develop a framework for delivering unbiased and evidence-based consumer education around cannabis as laid out in its nine founding pillars,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. “This opportunity extends the global reach of the Cannvas brand, opens doors to exciting new ventures and projects with partners spanning the globe, and strengthens our market position as a leader in cannabis education in Canada and across the world.”
Cannvas will work with the InterCannAlliance to deliver physician-backed and evidence-based cannabis education powered by its digital cannabis learning resource Cannvas.Me. With a focus on audiences in new and evolving legal cannabis markets, InterCannAlliance will review all original content on Cannvas.Me and work with the Cannvas team to identify appropriate learning modules to adapt and make available to their community. The partnership also opens the door to opportunities for Cannvas to explore projects with New Frontier Data as part of its cannabis analytics platform Cannvas Data, as the two organizations share the same mission of elevating the discussion around the legal cannabis industry globally by providing unbiased vetted information and educating stakeholders to make informed decisions.
The International Cannabis Alliance was created in March of 2018 to bring advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe. Its mission is to educate and inform future market and thought leaders interested in the cannabis industry, fostering responsible, transparent and effective market practices learned across more mature North American cannabis sectors.
Uniting recognized leaders from industry segments considered to be critical building blocks for any cannabis market, InterCannAlliance seeks to simplify the complex and inconsistent regulatory environments being implemented across and within nations. The InterCannAlliance conducts one-day, invitation-only regional symposia to foster collaboration among governments, non-governmental organizations and commercial enterprises to educate stakeholders about opportunities, risks, and challenges in these markets.
The International Cannabis Alliance (InterCannAlliance) was created in March of 2018 to bring advancements from existing legal cannabis markets to new and evolving legal cannabis markets around the globe. As established and emerging markets look to cannabis to reinvigorate their economies, healthcare and a range of industries, InterCannAlliance unites recognized leaders from industry segments considered to be critical building blocks for any cannabis market. The organization seeks to simplify the complex and inconsistent regulatory environments being implemented across and within nations and to help emerging markets capitalize on lessons learned elsewhere. The InterCannAlliance conducts invitation-only quarterly regional symposia to facilitate collaboration among governments, non-government organizations and large commercial enterprises to expedite access to and assessment of opportunities while accelerating growth. For more information, visit www.intercannalliance.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
For further information: firstname.lastname@example.org or visit Cannvas.com
Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), today announced the closing of its previously announced marketed public offering of 5,000,000 subordinate voting shares in the United States and Canada (the “Offering”) at a public offering price of C$50.00 per share ( $39.63 per share after giving effect to the conversion rate published by Bloomberg at 4:30pm ET on April 7, 2021 to convert Canadian dollars to U.S. dollars). In connection with the closing of the Offering, the underwriters exercised in full their option to purchase an additional 750,000 subordinate voting shares. As a result, the gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by Trulieve, were C$287.5 million (or $227.9 million after giving effect to the conversion rate denoted above).
The Offering was conducted through a syndicate of underwriters led by Canaccord Genuity, as sole book-running manager, and included Cormark Securities Inc., as co-lead manager, as well as ATB Capital Markets Inc., Echelon Wealth Partners Inc., Eight Capital and PI Financial Corp. All of the shares in the Offering were sold by Trulieve. Trulieve intends to use the net proceeds from the Offering primarily to fund Trulieve’s business development and for general working capital purposes.
Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or “ Ayurcann ”), is pleased to announce that the Company intends to complete a non-brokered private placement (the “Financing” ) of up to 2,645,503 units (the “Units” ) at a price of $0.189 per Unit. Each Unit will consist of one common share ( “Common Share” ) of the Company and one-half of a common share purchase warrant ( “Warrant” ), with each whole Warrant entitling the holder to acquire one additional Common Share at an exercise price of $0.38 per Common Share for a period of 36 months from the closing date ( “Closing Date” ) of the Financing, for gross proceeds of up to $500,000 .
The Company will have an option, prior to the closing date, to upsize the offering with the sale of an additional 25% of Units, accounting to aggregate proceeds of up to $625,000.
Lobe invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference
Nextleaf Solutions Receives Amendment to Standard Processing Licence to Allow for Direct to Province Sales
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary, Nextleaf Labs Ltd. (“Nextleaf Labs”), has received an amendment to its existing Standard Cannabis Processing Licence from Health Canada (the “Amendment” or the “Amended Licence”) that authorizes the sale of cannabis extracts, edibles, and topical products, directly to provincially-authorized distributors and retailers across Canada.